arsenicum album boiron 12ch pilules
boiron - arsenicum album 15ch 1 % - pillules - 12ch - arsenicum album 15ch 1 %
arsenicum iodatum boiron 5ch pilules
boiron - arsenicum iodatum 5ch 1 % - pillules - 5ch - arsenicum iodatum 5ch 1 %
arsenicum iodatum boiron 7ch pilules
boiron - arsenicum iodatum 7ch 1 % - pillules - 7ch - arsenicum iodatum 7ch 1 %
arsenicum iodatum boiron 9ch pilules
boiron - arsenicum iodatum 9ch 1 % - pillules - 9ch - arsenicum iodatum 9ch 1 %
arsenicum iodatum boiron 15ch pilules
boiron - arsenicum iodatum 15ch 1 % - pillules - 15ch - arsenicum iodatum 15ch 1 %
arsenicum iodatum boiron 30ch pilules
boiron - arsenicum iodatum 30ch 1 % - pillules - 30ch - arsenicum iodatum 30ch 1 %
arsenicum iodatum boiron 30k pilules
boiron - arsenicum iodatum 30k 1 % - pillules - 30k - arsenicum iodatum 30k 1 %
arsenicum iodatum boiron 200k pilules
boiron - arsenicum iodatum 200k 1 % - pillules - 200k - arsenicum iodatum 200k 1 %
arsenicum iodatum boiron 200k pilules single-dose cont.
boiron - arsenicum iodatum 200k 1 % - pillules in single-dose container - 200k - arsenicum iodatum 200k 1 %
arsenic trioxide accord arsenic trioxide 10 mg/10 ml injection vial
accord healthcare pty ltd - arsenic trioxide, quantity: 10 mg - injection, concentrated - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide - for the induction of remission and consolidation in patients with acute promyelocytic leukaemia (apl) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose apl is characterised by the presence of the t(15:17) translocation or pml/rar-alpha gene expression.,for the induction of remission and consolidation in patients with previously untreated acute promyelocytic leukaemia (apl) in combination with all-trans retinoic acid (atra) and/or chemotherapy and whose apl is characterised by the presence of the t(15:17) translocation or pml/rar-alpha gene expression.